BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31899189)

  • 1. Calcification of the cavernosal bodies may be responsible for development of erectile dysfunction in uremic apolipoprotein E deficient (apoE-/-) mice.
    Ivanovski O; Nikolov IG; Davceva O; Petrushevska G
    Rev Int Androl; 2021; 19(1):25-33. PubMed ID: 31899189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia.
    Buzello M; Törnig J; Faulhaber J; Ehmke H; Ritz E; Amann K
    J Am Soc Nephrol; 2003 Feb; 14(2):311-6. PubMed ID: 12538731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of endothelial function in a murine model of mild cholesterol-induced atherosclerosis by mineralocorticoid antagonism.
    Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
    Atherosclerosis; 2016 Aug; 251():291-298. PubMed ID: 27439215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
    Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
    Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis and vascular calcification in uraemia - a new experimental model.
    Ivanovski O; Nikolov IG; Drueke BT; Massy AZ
    Prilozi; 2007 Dec; 28(2):11-24. PubMed ID: 18356775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
    Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
    Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
    Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
    Bro S
    Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the development of vascular and renal lesions in mice with a simultaneous deficiency of
    Marek I; Canu M; Cordasic N; Rauh M; Volkert G; Fahlbusch FB; Rascher W; Hilgers KF; Hartner A; Menendez-Castro C
    Biol Sex Differ; 2017; 8():19. PubMed ID: 28572914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetuin-A protects against atherosclerotic calcification in CKD.
    Westenfeld R; Schäfer C; Krüger T; Haarmann C; Schurgers LJ; Reutelingsperger C; Ivanovski O; Drueke T; Massy ZA; Ketteler M; Floege J; Jahnen-Dechent W
    J Am Soc Nephrol; 2009 Jun; 20(6):1264-74. PubMed ID: 19389852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
    Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
    Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
    Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
    Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
    Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice.
    Behr-Roussel D; Darblade B; Oudot A; Compagnie S; Bernabé J; Alexandre L; Giuliano F
    J Sex Med; 2006 Jul; 3(4):596-603. PubMed ID: 16839315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis.
    Schlimmer N; Kratz M; Böhm M; Baumhäkel M
    Br J Pharmacol; 2011 Jun; 163(4):804-14. PubMed ID: 21323898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
    Nikolov IG; Joki N; Galmiche A; Nguyen-Khoa T; Guerrera IC; Guillonneau F; Ivanovski O; Phan O; Maizel J; Marçon F; Benchitrit J; Lucas A; Edelman A; Lacour B; Drüeke TB; Massy ZA
    Atherosclerosis; 2013 Jul; 229(1):42-51. PubMed ID: 23672878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
    Ivanovski O; Nikolov IG; Joki N; Caudrillier A; Phan O; Mentaverri R; Maizel J; Hamada Y; Nguyen-Khoa T; Fukagawa M; Kamel S; Lacour B; Drüeke TB; Massy ZA
    Atherosclerosis; 2009 Jul; 205(1):55-62. PubMed ID: 19118829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.